Literature DB >> 8392410

Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA.

C T Moraes1, F Ciacci, G Silvestri, S Shanske, M Sciacco, M Hirano, E A Schon, E Bonilla, S DiMauro.   

Abstract

Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is commonly associated with an A-->G transition at position 3243 of the mitochondrial DNA. To determine the diversity of clinical syndromes associated with this mutation, 91 patients with mitochondrial encephalomyopathies that did not conform to the MELAS phenotype were screened. Twenty one patients with the 3243 mutation, most of whom had progressive external ophthalmoplegia (PEO) were found. Clinical features did not distinguish PEO patients with the 3243 mutation from those with large-scale deletions of mtDNA. However, most cases with single large-scale mtDNA deletions were sporadic, whereas most patients with the 3243 mutation had affected maternal relatives. Histochemical studies of muscle showed that cytochrome c oxidase (COX) deficiency was more severe in patients with PEO than in patients with typical MELAS, even though PEO patients had a lower percentage of mutant genomes in muscle. These data imply that the 3243 mutation is a major cause of familial PEO, and suggests that the threshold number of mtDNAs harboring the 3243 mutation necessary to affect a particular tissue vary in different patients. The proportion of mutant genomes in combination with other, still undefined, tissue-specific modulating factors seem to determine the overall clinical syndrome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392410     DOI: 10.1016/0960-8966(93)90040-q

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  51 in total

Review 1.  Clinical mitochondrial genetics.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

Review 2.  Mitochondria.

Authors:  P F Chinnery; E A Schon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

3.  Chorea triggered by hyperglycemia in a maternally inherited diabetes and deafness (MIDD) patient with the A3243G mutation of mitochondrial DNA and basal ganglia calcification.

Authors:  Ji-Hoon Kang; Sa-Yoon Kang; Jay-Chol Choi; Seong-Suk Lee; Ji-Soo Kim
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

Review 4.  [Gene expression profiling of classic mitochondrial disorders. Its value in finding therapeutic strategies].

Authors:  S Mende; A Storch; H Reichmann
Journal:  Nervenarzt       Date:  2007-10       Impact factor: 1.214

5.  A novel tRNA(Val) mitochondrial DNA mutation causing MELAS.

Authors:  Kurenai Tanji; Petra Kaufmann; Ali B Naini; Jiesheng Lu; Timothy C Parsons; Dong Wang; Joshua Z Willey; Sara Shanske; Michio Hirano; Eduardo Bonilla; Alexander Khandji; Salvatore Dimauro; Lewis P Rowland
Journal:  J Neurol Sci       Date:  2008-03-07       Impact factor: 3.181

Review 6.  The clinical maze of mitochondrial neurology.

Authors:  Salvatore DiMauro; Eric A Schon; Valerio Carelli; Michio Hirano
Journal:  Nat Rev Neurol       Date:  2013-07-09       Impact factor: 42.937

Review 7.  Mitochondrial genotype and clinical phenotype.

Authors:  P F Chinnery; D M Turnbull
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

8.  The mitochondrial A3243G mutation presenting as severe cardiomyopathy.

Authors:  L Vilarinho; F M Santorelli; M J Rosas; C Tavares; M Melo-Pires; S DiMauro
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

9.  Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases.

Authors:  P Seibel; J Trappe; G Villani; T Klopstock; S Papa; H Reichmann
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

10.  Mitochondrial Respiratory Disorders: A Perspective on their Metabolite Biomarkers and Implications for Clinical Diagnosis and Therapeutic Intervention.

Authors:  Martine Uittenbogaard; Anne Chiaramello
Journal:  Biomark J       Date:  2015-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.